The company will use the proceeds to test its gene therapy XC001 in two Phase II studies involving patients with cardiovascular disease.

Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...

After a heart attack, humans lose millions of heart muscle cells that cannot regrow, often leading to heart failure where the ...

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

The new name draws from the company’s nearly two decades of work in ryanodine receptor (RyR) biology, which it has used to ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

With dropping temperatures in many parts of the country, the general public is reminded of the accompanying risk of heart ...

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving ...